CVS Corp Stock Analysis

CVS
 Stock
  

USD 94.52  2.15  2.33%   

CVS Corp price fall over the last few months could raise concerns from retail investors as the firm is trading at a share price of 94.52 on very low momentum in volume. The company management teams were not very successful in positioning the firm resources to exploit market volatility in May. However, diversifying your holdings with CVS Corp or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.81. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Continue to Trending Equities.
  
Refresh
The CVS Corp stock analysis report makes it easy to digest most publicly released information about CVS Corp and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. CVS Corp Stock analysis module also helps to analyze the CVS Corp price relationship with some important fundamental indicators such as market cap and management efficiency.

CVS Corp Stock Analysis Notes

About 80.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.62. Some equities with similar Price to Book (P/B) outperform the market in the long run. CVS Corp has Price/Earnings To Growth (PEG) ratio of 2.05. The entity recorded earning per share (EPS) of 5.73. The firm next dividend is scheduled to be issued on the 21st of April 2022. CVS Corp had 2:1 split on the 7th of June 2005. CVS Health Corporation provides health services in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 216000 people. For more info on CVS Corp please contact Karen Lynch at 401 762-2137 or go to www.cvshealth.com.

CVS Corp Quarterly Cost of Revenue

63.46 Billion

Share

CVS Corp Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. CVS Corp's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding CVS Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
CVS Corp generated a negative expected return over the last 90 days
The company has 76 B in debt with debt to equity (D/E) ratio of 1.01, which is OK given its current industry classification. CVS Corp has a current ratio of 0.86, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist CVS Corp until it has trouble settling it off, either with new capital or with free cash flow. So, CVS Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CVS Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CVS Corp to invest in growth at high rates of return. When we think about CVS Corp's use of debt, we should always consider it together with cash and equity.
CVS Corp has a strong financial position based on the latest SEC filings
Over 80.0% of CVS Corp shares are held by institutions such as insurance companies
Latest headline from www.fiercepharma.com: CVS Health returns BMS, Pfizers Eliquis to formulary - FiercePharma

CVS Corp Upcoming and Recent Events

Earnings reports are used by CVS Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CVS Corp previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report9th of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End9th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

CVS Corp Largest EPS Surprises

Earnings surprises can significantly impact CVS Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1997-02-05
1996-12-310.10.110.0110 
1999-04-28
1999-03-310.190.210.0210 
1997-04-24
1997-03-310.110.130.0218 
View All Earnings Estimates

CVS Corp SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. CVS Corp prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that CVS Corp investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial CVS Corp specific information freely available to individual and institutional investors to make a timely investment decision.
9th of June 2022
Regulation FD Disclosure
View
16th of May 2022
Financial Statements and Exhibits. Other Events. Submission of Matters to a Vote of Security Holders
View
4th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
30th of March 2022
Financial Statements and Exhibits. Other Events
View
25th of March 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
10th of March 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
9th of February 2022
Financial Statements and Exhibits. Unclassified Corporate Event. Results of Operations and Financial Condition
View
31st of January 2022
Unclassified Corporate Event
View

CVS Corp Thematic Classifications

In addition to having CVS Corp stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Macroaxis Index IdeaMacroaxis Index
Macroaxis power theme of selected equities with solid fundamentals
Retail IdeaRetail
USA Equities from Retail industry as classified by Fama & French
Health Management IdeaHealth Management
Healthcare providers, hospitals
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French

CVS Corp Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as CVS Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CVS Corp backward and forwards among themselves. CVS Corp's institutional investor refers to the entity that pools money to purchase CVS Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares111.9 M11.3 B
Blackrock IncCommon Shares93 M9.4 B
State Street CorpCommon Shares59.3 MB
Capital World InvestorsCommon Shares58.6 M5.9 B
Capital International InvestorsCommon Shares28.1 M2.8 B
Jpmorgan Chase CoCommon Shares24 M2.4 B
Morgan StanleyCommon Shares22.8 M2.3 B
Note, although CVS Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

CVS Corp Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 120.51 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CVS Corp's market, we take the total number of its shares issued and multiply it by CVS Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

CVS Corp Profitablity

CVS Corp's profitability indicators refer to fundamental financial ratios that showcase CVS Corp's ability to generate income relative to its revenue or operating costs. If, let's say, CVS Corp is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, CVS Corp's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of CVS Corp's profitability requires more research than a typical breakdown of CVS Corp's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 2.72 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is considered to be average in the sector. In the same way, it shows Net Operating Margin of 6.29 %, which entails that for every 100 dollars of revenue, it generated 0.06 of operating income.
Last ReportedProjected for 2022
Return on Investment 9.95  12.74 
Return on Average Assets 0.034  0.038 
Return on Average Equity 0.11  0.10 
Return on Invested Capital 0.1  0.14 
Return on Sales 0.044  0.0447 

Management Efficiency

The entity has Return on Asset of 3.71 % which means that on every $100 spent on asset, it made $3.71 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 10.89 %, implying that it generated $10.89 on every 100 dollars invested. CVS Corp management efficiency ratios could be used to measure how well cvs corp manages its routine affairs as well as how well it operates its assets and liabilities. CVS Corp Return on Investment is relatively stable at the moment as compared to the past year. CVS Corp reported last year Return on Investment of 9.95. As of 06/26/2022, Return on Average Assets is likely to grow to 0.038, while Return on Average Equity is likely to drop 0.10. CVS Corp Revenue to Assets are relatively stable at the moment as compared to the past year. CVS Corp reported last year Revenue to Assets of 1.25. As of 06/26/2022, Total Assets Per Share is likely to grow to 190.16, while Current Assets are likely to drop slightly above 52.3 B.
Last ReportedProjected for 2022
Book Value per Share 56.92  53.18 
Enterprise Value over EBIT 16.00  16.21 
Enterprise Value over EBITDA 11.75  12.06 
Price to Book Value 1.81  1.76 
Tangible Assets Book Value per Share 94.66  79.91 
Enterprise Value205 B177.7 B
Tangible Asset Value124.9 B102.1 B

Technical Drivers

As of the 26th of June, CVS Corp shows the mean deviation of 1.32, and Risk Adjusted Performance of (0.13). CVS Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for CVS Corp, which can be compared to its rivals. Please confirm CVS Corp variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if CVS Corp is priced some-what accurately, providing market reflects its regular price of 94.52 per share. Given that CVS Corp has jensen alpha of (0.046494), we suggest you to validate CVS Corp's prevailing market performance to make sure the company can sustain itself at some point in the future.

CVS Corp Price Movement Analysis

The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Simple Moving Average indicator is calculated by adding the closing price of CVS Corp for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out CVS Corp short-term fluctuations and highlight longer-term trends or cycles.
.

CVS Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CVS Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on CVS Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CVS Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chaguturu Sreekanth K over two weeks ago via Macroaxis 
CVS Corp exotic insider transaction detected
David Dorman over three weeks ago via Macroaxis 
Acquisition by David Dorman of tradable shares of CVS Corp subject to Rule 16b-3
James Clark over two months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Daniel Finke over two months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Prem Shah over two months ago via Macroaxis 
Sale by Prem Shah of 2935 shares of CVS Corp
Daniel Finke over two months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Prem Shah over two months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Thomas Moriarty over three months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Prem Shah over three months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Thomas Moriarty over three months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Daniel Finke over three months ago via Macroaxis 
CVS Corp exotic insider transaction detected
Karen Lynch over three months ago via Macroaxis 
CVS Corp exotic insider transaction detected

CVS Corp Outstanding Bonds

CVS Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CVS Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CVS Corp bonds can be classified according to their maturity, which is the date when CVS Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

CVS Corp Technical and Predictive Indicators

CVS Corp Forecast Models

CVS Corp time-series forecasting models is one of many CVS Corp's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CVS Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About CVS Corp Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how CVS Corp stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CVS Corp shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as CVS Corp. By using and applying CVS Corp Stock analysis, traders can create a robust methodology for identifying CVS Corp entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 4.52  5.49 
EBITDA Margin 0.06  0.06 
Gross Margin 0.18  0.17 
Profit Margin 0.0243  0.0246 
CVS Health Corporation provides health services in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 216000 people.

Current CVS Corp Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CVS Corp analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CVS Corp analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
111.0Buy17Odds
CVS Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most CVS Corp analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CVS Corp stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CVS Corp, talking to its executives and customers, or listening to CVS Corp conference calls.
CVS Corp Analyst Advice Details

CVS Corp Stock Analysis Indicators

CVS Corp stock analysis indicators help investors evaluate how CVS Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CVS Corp shares will generate the highest return on investment. By understating and applying CVS Corp stock analysis, traders can identify CVS Corp position entry and exit signals to maximize returns.
Quick Ratio0.55
Trailing Annual Dividend Rate2.00
Fifty Two Week Low79.33
Payout Ratio34.11%
Average Daily Volume Last 10 Day5.03M
Shares Short Prior Month11.26M
Average Daily Volume In Three Month5.5M
Shares Percent Shares Out1.06%
Gross Margins17.48%
Forward Price Earnings10.19
Short Percent Of Float1.07%
Float Shares1.31B
Fifty Two Week High111.25
Fifty Day Average97.86
Enterprise Value To Ebitda10.39
Two Hundred Day Average97.23
Enterprise Value To Revenue0.65
Trailing Annual Dividend Yield2.20%
Continue to Trending Equities. Note that the CVS Corp information on this page should be used as a complementary analysis to other CVS Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for CVS Corp Stock analysis

When running CVS Corp price analysis, check to measure CVS Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Corp is operating at the current time. Most of CVS Corp's value examination focuses on studying past and present price action to predict the probability of CVS Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CVS Corp's price. Additionally, you may evaluate how the addition of CVS Corp to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is CVS Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Corp. If investors know CVS Corp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.036
Market Capitalization
123.9 B
Quarterly Revenue Growth YOY
0.11
Return On Assets
0.0386
Return On Equity
0.11
The market value of CVS Corp is measured differently than its book value, which is the value of CVS Corp that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Corp's value that differs from its market value or its book value, called intrinsic value, which is CVS Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Corp's market value can be influenced by many factors that don't directly affect CVS Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine CVS Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.